Skip to main content

Pre-Market Buzz: bluebird bio (BLUE), PlasmaTech (PTBI), AirMedia (AMCN), Twitter (TWTR)

Shares of bluebird bio, Inc. (BLUE) are higher by nearly 6 points to $116 in pre-market trading on Monday after the company reported new data from HGB-205 study. The clinical-stage biotechnology firm said patients with beta-thalassemia major remain transfusion-independent at 16 and 14 Months. “These data are promising for patients living with beta-thalassemia major and […] View the full post at: Pre-Market Buzz: bluebird bio (BLUE), PlasmaTech (PTBI), AirMedia (AMCN), Twitter (TWTR) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock The Uber Nutrient Worth “Hundreds of Billions” Japan’s Shionogi To Acquire Sciele Pharma (SCRX) for $1.42 Billion
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.